Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00469157 · ClinicalTrials.gov registry record · Phase 4

Refractive Surgery and Optive Compatibility Study

A Phase 4 study, sponsored by Innovative Medical.

Completed
Registry status
Phase 4
Development phase
92
Enrollment target

NCT00469157: Completed Phase 4 study, sponsored by Innovative Medical.

NCT00469157 is a Phase 4 study that has completed, run by Innovative Medical. The registered enrollment target is 92 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00469157, a Phase 4 study, has completed, sponsored by Innovative Medical.

COMPLETED
Registry status
Phase 4
Development phase
92 participants
Enrollment target

Study Summary

To assess the compatibility of Optive with refractive surgery (PRK and LASIK) post-operatively.

Interventions

  • DRUG Optive

Trial Details

FieldValue
Enrollment Target 92 participants
Start Date 2007-05
Est. Completion 2008-04
Phase Phase 4
Innovative Medical

44 total trials

What the finished NCT00469157 record still lists

NCT00469157 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 92 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (82% lower).

The record links to 0 conditions, and to 1 intervention - of which Optive is the first listed.

NCT00469157 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00469157 about?

NCT00469157 is a clinical study titled "Refractive Surgery and Optive Compatibility Study". To assess the compatibility of Optive with refractive surgery (PRK and LASIK) post-operatively.

What is the current status of trial NCT00469157?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 92 participants. The study started on 2007-05. Estimated completion is 2008-04.

What interventions are being tested in trial NCT00469157?

The interventions under investigation include: Optive (DRUG).

Who is sponsoring clinical trial NCT00469157?

This trial is sponsored by Innovative Medical, which has 44 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00469157's enrollment target sits among peer trials

92 876th of 2000 higher than 1,117 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03184545 · 92 participants · Phase 3

    Comparing the Outcome of Electrical Stimulation and Physical Therapy in Patellofemoral Pain Syndrome

  • NCT04172532 · 92 participants · Phase 1

    Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

  • NCT04508088 · 92 participants

    Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease

  • NCT04840602 · 92 participants · Phase 2

    Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00469157, the US trial registry maintained by the National Library of Medicine. NCT00469157 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.